Key facts
- It has raised $20.4M; the latest was Early Stage VC ($10.1M) in Jun 2025.
- Notable investors include Korea Development Bank, Bass Investment, LB Investment, LSK Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for MediBuilder
- ·The full record, as it builds
Funding rounds
No funding rounds for MediBuilder are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MediBuilder
Developer of medical device commercialization platform intended to diagnose the initial idea of systems. The company's platform provides a comprehensive set of tools and resources for medical device developers, including market research, regulatory guidance, and technical support, enabling developers to bring their products to market more quickly and efficiently, improving patient care and reducing costs.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2022
- Employees
- 47
- Ownership
- Privately Held (backing)
MediBuilder doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MediBuilder shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MediBuilder in its N-PORT filings yet. We sweep new filings monthly.